Hongli Tang Selected Research

Cell- and Tissue-Based Therapy (Cell Therapy)

1/2020

Recent Advances in Immune Cell Therapy for Glioblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hongli Tang Research Topics

Disease

5	Neoplasms (Cancer) 12/2021 - 04/2006
4	Stroke (Strokes) 01/2022 - 01/2019
4	Ischemic Stroke 01/2022 - 01/2019
4	Brain Ischemia (Cerebral Ischemia) 01/2021 - 01/2020
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2021 - 01/2020
3	Neuroinflammatory Diseases 01/2021 - 01/2019
2	Pain (Aches) 01/2021 - 08/2013
2	Reperfusion Injury 01/2021 - 01/2020
2	Inflammation (Inflammations) 01/2020 - 04/2006
2	Lung Neoplasms (Lung Cancer) 01/2011 - 07/2008
1	Malignant Hyperthermia 01/2022
1	Muscular Diseases (Myopathy) 01/2022
1	Carcinoma (Carcinomatosis) 12/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2021
1	Acute Pain 01/2021
1	Ischemia 01/2021
1	Hypotension (Low Blood Pressure) 09/2020
1	Tachycardia (Tachyarrhythmias) 09/2020
1	Wounds and Injuries (Trauma) 09/2020
1	Hypertension (High Blood Pressure) 09/2020
1	Neurobehavioral Manifestations 01/2020
1	Cerebral Infarction 01/2020
1	Brain Injuries (Brain Injury) 01/2020
1	Glioblastoma (Glioblastoma Multiforme) 01/2020
1	Neuroblastoma 01/2020
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2020
1	Infarction (Infarctions) 01/2020
1	Chronic Disease (Chronic Diseases) 11/2018
1	Emergence Delirium 01/2015
1	Squamous Cell Carcinoma of Head and Neck 06/2007
1	Adenocarcinoma 04/2006
1	Carcinogenesis 04/2006

Drug/Important Bio-Agent (IBA)

2	von Willebrand FactorIBA 01/2021 - 01/2019
2	Pharmaceutical PreparationsIBA 01/2021 - 07/2008
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2020
2	SmokeIBA 01/2011 - 07/2008
2	Biological ProductsIBA 07/2008 - 06/2007
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2022
1	Neuroprotective AgentsIBA 01/2022
1	MK-8722IBA 12/2021
1	OrexinsIBA 01/2021
1	peoniflorinIBA 01/2021
1	Huang QiIBA 01/2021
1	astragaloside AIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Dexmedetomidine FDA Link 09/2020
1	JNK-IN-8IBA 01/2020
1	Mitogen-Activated Protein KinasesIBA 01/2020
1	Adenosine A1 ReceptorIBA 01/2020
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2020
1	Adenosine (Adenocard)FDA LinkGeneric 01/2020
1	JNK Mitogen-Activated Protein KinasesIBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Anesthetics (Anesthetic Agents)IBA 11/2018
1	flurbiprofen axetilIBA 01/2015
1	Sufentanil (Sufenta)FDA LinkGeneric 01/2015
1	Analgesics (Analgesic Drugs)IBA 01/2015
1	Morphine (MS Contin)FDA LinkGeneric 08/2013
1	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 08/2013
1	Opioid Analgesics (Opioids)IBA 08/2013
1	Melanoma-Specific AntigensIBA 01/2011
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2011
1	ErbB Receptors (EGF Receptor)IBA 06/2007
1	LigandsIBA 04/2006
1	Chemokine ReceptorsIBA 04/2006

Therapy/Procedure

3	Therapeutics 01/2022 - 07/2008
2	Analgesia 09/2020 - 08/2013
1	Drug Therapy (Chemotherapy) 01/2020
1	Radiotherapy 01/2020
1	Electroacupuncture 01/2020
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2020
1	Intravenous Administration 01/2019
1	Patient-Controlled Analgesia (Analgesia, Patient Controlled) 08/2013
1	Immunotherapy 01/2011